Effect of SGLT-2 inhibitor on myocardial perfusion, function and metabolism in type 2 diabetes at high cardiovascular risk: The SIMPLe randomized clinical trial
Funder: Novo Nordisk Fonden
Amount: DKK 1,998,000
Funding type: research
Funder scheme: Steno Collaborative Project Grants
Start date: 2017-01-01
Investigator: Caroline Kistorp (lead)
Institution: Herlev Hospital
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: nnf-grant-50816f320784212b
OpenAlex ID: G7075063470